Physician profile
Mark Rothschild
NPI 1811983083
$1,611.64
in general payments reported to CMS, 2019-2025
22 companies · $195 in 2025
The $195 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $256 · 2020: $77.52 · 2021: $113 · 2022: $359 · 2023: $385 · 2024: $226 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $806.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $805.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $255.68 | 2022-2025 | Watchman Flx |
| Pfizer INC. | $230.32 | 2020-2025 | |
| Novartis Pharmaceuticals Corporation | $181.86 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $153.29 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $140.28 | 2023-2024 | Farxiga, Brilinta |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $107.42 | 2021-2024 | Lifevest |
| Esperion Therapeutics, INC. | $89.09 | 2020-2022 | |
| Edwards Lifesciences Corporation | $84.46 | 2019 | |
| Biosense Webster, INC. | $77.03 | 2019-2022 | |
| Abbott Laboratories | $61.26 | 2021-2022 | |
| Welch Allyn | $38.13 | 2021 | |
| Alnylam Pharmaceuticals INC. | $27.87 | 2024 | Onpattro |
| Atricure, INC. | $24.89 | 2019 | |
| Medtronic Vascular, INC. | $21.88 | 2019 | |
| Amarin Pharma, INC. | $18.80 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $16.84 | 2023 | |
| Amgen INC. | $15.92 | 2022 | |
| Sanofi-Aventis U.S. LLC | $15.54 | 2022 | |
| Baxter Healthcare | $14.87 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| E.R. Squibb & Sons, L.L.C. | $14.22 | 2022 | |
| Novo Nordisk INC | $11.99 | 2022 | |
| Bardy Diagnostics, INC. | $10.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Rothschild listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.